Chad Stiening Email

CEO . Kypha

Current Roles

Employees:
32
Revenue:
$8M
About
Biosensia is a Point-of-Care in-vitro diagnostics company that has a novel point-of-care platform, RapiPlex, available for licensing. RapiPlex combines highly innovative technologies to produce a practical, rapid, multiplexing POC in-vitro diagnostics (IVD) platform, enabling access to a broad range of diagnostic applications. Its component chip and cartridge system are compatible with a variety of common biological sample types, including whole blood, serum, saliva, urine and nasal/genital swabs.
Kypha Address
4320 Forest Park Ave
Dublin, null
Kypha Email

Past Companies

KyphaCEO
Synchrony BioCo-Founder & Managing Director
Common Place HoldingsFounder, Managing Partner

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.